← Leaderboards
Gary Kohanbash
University Of Pittsburgh At Pittsburgh
$2,860,670
Attributed
$5,721,339
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,721,339 · 5
By mechanism
R01$4,382,459 · 2
R21$1,338,880 · 3
Top collaborators
- Wilson Barry Edwards9 shared
- Marcus M. Malek3 shared
- Ruchira Menka Jha2 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Ruchira Menka Jha$3,983,339
- Elizabeth Renee Skidmore$3,053,785
- Jun Chen$22,616,112
- Timothy Edward Corcoran$4,686,288
- Cynthia R Johnson$3,317,262
Others in their field
Other Emerging Leaders on “Pre-Clinical”
- Leonard Freedman · Leidos Biomedical Research, Inc.$264,541,531
- Lynn Briscoe · Leidos Biomedical Research, Inc.$110,540,429
- Ted Ross · University Of Georgia$68,763,143
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$57,713,529
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
Research focus
Pre-ClinicalTumorTracerAntibodiesUptakeLabelExcisionPreventCellsMonitorPublic HealthAdultMolecularNoninvasive DiagnosisGliomaImmunoglobulin FragmentsPositron-Emission TomographyDiagnostic ImagingDetectionResponseInnovationCross ReactivityImmunotherapyMission
Grant awards (14)
Intraoperative dual-labeled molecular tracer to improve surgery on neuroblastoma$582,580
R01 · FY2025 · CA
Intraoperative dual-labeled molecular tracer to improve surgery on neuroblastoma$545,270
R01 · FY2024 · CA
Engineered antibody fragments for PET imaging of immunotherapeutic targets in gliomas$504,471
R01 · FY2024 · CA · contact PI
A Single Cell and Proteomic Precision Medicine Approach to Glyburide Responsive Contusion Expansion in Severe Traumatic Brain Injury$227,588
R21 · FY2024 · NS
Intraoperative dual-labeled molecular tracer to improve surgery on neuroblastoma$596,251
R01 · FY2023 · CA
Engineered antibody fragments for PET imaging of immunotherapeutic targets in gliomas$528,929
R01 · FY2023 · CA · contact PI
A Single Cell and Proteomic Precision Medicine Approach to Glyburide Responsive Contusion Expansion in Severe Traumatic Brain Injury$251,954
R21 · FY2023 · NS
Engineered antibody fragments for PET imaging of immunotherapeutic targets in gliomas$528,929
R01 · FY2022 · CA · contact PI
Engineered antibody fragments for PET imaging of immunotherapeutic targets in gliomas$550,016
R01 · FY2021 · CA · contact PI
Engineered Antibodies as PET Probes for Monitoring Immunotherapy Responses$234,750
R21 · FY2021 · EB · contact PI
Engineered antibody fragments for PET imaging of immunotherapeutic targets in gliomas$546,013
R01 · FY2020 · CA · contact PI
Engineered Antibodies as PET Probes for Monitoring Immunotherapy Responses$195,625
R21 · FY2020 · EB · contact PI
CD11b Antibody Fragments as PET Imaging Probes for Glioma-Associated Myeloid Cells$234,185
R21 · FY2019 · EB
CD11b Antibody Fragments as PET Imaging Probes for Glioma-Associated Myeloid Cells$194,778
R21 · FY2018 · EB